FDA Inspection
Janssen Sciences Ireland UCJanssen Sciences Ireland UC – FDA Inspection, Mar 3, 2017
Record Details
This FDA Inspection record concerns Janssen Sciences Ireland UC, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · de13679c-47e3-4468-a150-9d03802586f7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1005677
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Janssen Sciences Ireland UC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 12, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2017 | Not classified | Office of Inspections and Investigations | |
| March 7, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Janssen Sciences Ireland UC
- FDA Inspection 1242369 - 2024-01-12
- FDA Inspection 1118429 - 2018-04-20
- FDA Inspection 1025026 - 2017-07-21
- FDA Inspection 869804 - 2014-03-07
- FDA Inspection 788455 - 2012-06-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.